Showing results (701-710 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 17, 2014
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trialsJoyce S Lee, Harold R Collard, Kevin J Anstrom, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsiesArnaud W Thille, Andrés Esteban, Pilar Fernández-Segoviano, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Pulmonary drug delivery: from generating aerosols to overcoming biological barriers-therapeutic possibilities and technological challengesChristian A Ruge, Julian Kirch, Claus-Michael Lehr
The Lancet. Respiratory Medicine|January 17, 2014
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort studyFerran Morell, Ana Villar, María-Ángeles Montero, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trialsLui G Franciosi, Zuzana Diamant, Katharine H Banner, et al.
The Lancet. Respiratory Medicine|January 17, 2014
Early lung development: lifelong effect on respiratory health and diseaseJanet Stocks, Alison Hislop, Samatha Sonnappa
The Lancet. Respiratory Medicine|May 25, 2023
Is low-risk status a surrogate outcome in pulmonary arterial hypertension? An analysis of three randomised trialsBryan S Blette, Jude Moutchia, Nadine Al-Naamani, et al.
The Lancet. Respiratory Medicine|May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre studyTao Huang, Sheng Zhang, De-Fang Dai, et al.
The Lancet. Respiratory Medicine|April 17, 2015
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsSteven Pascoe, Nicholas Locantore, Mark T Dransfield, et al.
The Lancet. Respiratory Medicine|April 15, 2021
Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responsesWoo-Jung Song, Christopher K M Hui, James H Hull, et al.
Pageof 104